By Karen Roman
DecisionRx said it appointed Michael Tilton as Chief Growth Officer to lead the expansion of the company’s Medication Therapy Optimization platform.
Tilton’s previous roles include senior vice president at Humana, as well as other senior leadership positions at UnitedHealth and Cigna, among others, the company said in a statement.
“DecisionRx has been implemented by payers and accountable care organizations (ACOs) across the US, and Michael has joined the team to accelerate adoption of our MTO platform by even more organizations” said Travis Morgan, the company’s co-founder and president. “Michael’s deep industry experience and professional network will be instrumental as we continue to expand our footprint with ACOs, Medicare Plans, and Employers.”
Contact:
